PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
+17.9%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$15.4B
AUM Growth
–
Cap. Flow
+$15.4B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
26.84%
Holding
317
New
317
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Apple
AAPL
|
$768M |
| 2 |
Microsoft
MSFT
|
$710M |
| 3 |
Meta Platforms (Facebook)
META
|
$546M |
| 4 |
Amazon
AMZN
|
$373M |
| 5 |
Advanced Micro Devices
AMD
|
$354M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 38.38% |
| 2 | Healthcare | 19.7% |
| 3 | Financials | 14.71% |
| 4 | Communication Services | 12.81% |
| 5 | Consumer Discretionary | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Molina Healthcare
MOH
$9.47B
| $45.6M | 0.28% |
+214,532
| New | +$45.6M |
|
|
OXFD
102
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $44.9M | 0.27% |
+2,568,385
| New | +$44.9M |
|
|
AXNX
103
DELISTED
Axonics, Inc. Common Stock
AXNX
| $44.8M | 0.27% |
+897,689
| New | +$44.8M |
|
|
ANSS
104
DELISTED
Ansys
ANSS
| $44.1M | 0.27% |
+121,331
| New | +$44.1M |
|
105
Merit Medical Systems
MMSI
$5.51B
| $38.2M | 0.23% |
+688,231
| New | +$38.2M |
|
106
Biogen
BIIB
$20.6B
| $36.7M | 0.22% |
+150,000
| New | +$36.7M |
|
|
CCXI
107
DELISTED
ChemoCentryx, Inc.
CCXI
| $36M | 0.22% |
+581,194
| New | +$36M |
|
|
SPLK
108
DELISTED
Splunk Inc
SPLK
| $35.9M | 0.22% |
+211,584
| New | +$35.9M |
|
109
James River Group
JRVR
$249M
| $35.6M | 0.22% |
+725,000
| New | +$35.6M |
|
110
Option Care Health
OPCH
$4.72B
| $35M | 0.21% |
+2,239,506
| New | +$35M |
|
111
Citigroup
C
$176B
| $34.3M | 0.21% |
+556,794
| New | +$34.3M |
|
112
Haemonetics
HAE
$2.62B
| $34.3M | 0.21% |
+289,090
| New | +$34.3M |
|
|
CHNGU
113
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
| $34.3M | 0.21% |
+535,000
| New | +$34.3M |
|
114
Cloudflare
NET
$74.7B
| $32.8M | 0.2% |
+431,804
| New | +$32.8M |
|
|
RVNC
115
DELISTED
Revance Therapeutics, Inc.
RVNC
| $32.7M | 0.2% |
+1,154,734
| New | +$32.7M |
|
116
Cognex
CGNX
$7.55B
| $32.2M | 0.2% |
+401,303
| New | +$32.2M |
|
117
First American
FAF
$6.83B
| $31M | 0.19% |
+600,000
| New | +$31M |
|
118
BioMarin Pharmaceuticals
BMRN
$11.1B
| $30.7M | 0.19% |
+350,000
| New | +$30.7M |
|
119
T-Mobile US
TMUS
$284B
| $30M | 0.18% |
+222,334
| New | +$30M |
|
120
Elevance Health
ELV
$70.6B
| $29.9M | 0.18% |
+93,222
| New | +$29.9M |
|
121
Enovis
ENOV
$1.84B
| $29.7M | 0.18% |
+450,862
| New | +$29.7M |
|
122
Envista
NVST
$3.54B
| $29.3M | 0.18% |
+867,595
| New | +$29.3M |
|
|
CNST
123
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $28.8M | 0.17% |
+1,000,000
| New | +$28.8M |
|
124
RLI Corp
RLI
$6.16B
| $28.6M | 0.17% |
+550,000
| New | +$28.6M |
|
125
Centene
CNC
$14.2B
| $28.5M | 0.17% |
+474,098
| New | +$28.5M |
|